Sickle cell disease is responsible for significant early mortality in Burkina Faso.
Burkina Fasodrépanocytosepublished 2023Le Mali medicaleurope_pmcdocument of 4 observations
Explore evidence
Gold tier: mechanically validated evidence, with its primary source.
3 evidence items · page 1 / 1
95.4 %95.4% of pregnant women with hemoglobinopathy had never heard of neonatal screening for sickle cell disease.
Burkina Fasodrépanocytoseobserved 2019published 2023Le Mali medicaleurope_pmcdocument of 4 observations
4 %In Côte d’Ivoire and its neighbouring countries (Ghana, Burkina Faso and Mali), the prevalence of sickle cell genetic traits is between 4% and 25%.
Burkina Faso · Ghana · MalidrépanocytoseHAL · Unilimdocument of 59 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.